n-(2-hydroxypropyl)methacrylamide has been researched along with Lymphoma, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etrych, T; Kostka, L; Kostková, H; Kovář, M; Ríhová, B; Starovoytová, L; Ulbrich, K | 1 |
| Fang, Y; Kopeček, J; Yang, J; Zhang, L | 1 |
2 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Lymphoma, B-Cell
| Article | Year |
|---|---|
HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
Topics: Acrylamides; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Lewis Lung; Cell Line, Tumor; Cytotoxins; Disulfides; Doxorubicin; Drug Carriers; Drug Therapy, Combination; Female; Kinetics; Levulinic Acids; Lymphoma, B-Cell; Lymphoma, T-Cell; Mammary Glands, Animal; Mice; Mice, Inbred C57BL; Mitomycin; Neoplasm Transplantation; Survival Analysis; Tumor Burden | 2013 |
A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin's lymphomas.
Topics: Acrylamides; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Epirubicin; Fluorescent Dyes; Heterografts; Humans; Lymphoma, B-Cell; Male; Mice, SCID; Microscopy, Confocal; Neoplasm Transplantation; Rituximab; Tissue Distribution | 2017 |